Publications in collaboration with researchers from Hospital Ramón y Cajal (28)

2024

  1. Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis

    Frontiers in Neurology , Vol. 15

2023

  1. Real-life safety and effectiveness outcomes of teriflunomide in patients with relapsing–remitting multiple sclerosis: The TERICAM study

    Neurology Perspectives, Vol. 3, Núm. 4

  2. Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in Immunology, Vol. 14

  3. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)

    Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30

  4. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)

    Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60

2022

  1. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

  2. Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 59

  3. Endarterectomy, Stenting, or Medical Treatment for Symptomatic Carotid Near-Occlusion: Results from CAOS, a Multicenter Registry Study

    American Journal of Neuroradiology, Vol. 43, Núm. 9, pp. 1304-1310

  4. Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis

    Multiple Sclerosis and Related Disorders

2021

  1. Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment

    Multiple Sclerosis and Related Disorders, Vol. 49

  2. Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 8, Núm. 2

  3. Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

    Frontiers in Immunology, Vol. 12

  4. Risk and outcomes of COVID-19 in patients with multiple sclerosis

    European Journal of Neurology, Vol. 28, Núm. 11, pp. 3712-3721

  5. Ultrasonographic and hemodynamic characteristics of patients with symptomatic carotid near-occlusion: results from a multicenter registry study

    Neuroradiology

  6. XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)

    Revista de neurologia, Vol. 72, Núm. 11, pp. 397-406

  7. XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II)

    Revista de neurologia, Vol. 72, Núm. 12, pp. 433-442

2020

  1. Comment on the article “Symptomatic carotid near-occlusion causes a high risk of recurrent ipsilateral ischemic stroke” by Gu et al.

    Journal of Neurology

  2. New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

    Frontiers in Neurology, Vol. 11

  3. Progression of carotid near-occlusion to complete occlusion: Related factors and clinical implications

    Journal of NeuroInterventional Surgery, Vol. 12, Núm. 12, pp. 1180-1185

  4. Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study

    CNS Drugs, Vol. 34, Núm. 12, pp. 1275-1286